相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents
Thomas Ebenhan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The ever-increasing importance of cancer as a leading cause of premature death worldwide
Freddie Bray et al.
CANCER (2021)
Advantages of 99mTc-3PRGD2 SPECT over CT in the preoperative assessment of lymph node metastasis in patients with esophageal cancer
Ningning Lv et al.
ANNALS OF NUCLEAR MEDICINE (2019)
[99mTc]3PRGD2 for integrin receptor imaging of esophageal cancer: a comparative study with [18F]FDG PET/CT
Shan Zheng et al.
ANNALS OF NUCLEAR MEDICINE (2019)
Comparison of [Tc-99m]3PRGD(2) Imaging and [F-18]FDG PET/CT in Breast Cancer and Expression of Integrin alpha(v)beta(3) in Breast Cancer Vascular Endothelial Cells
Zhenying Chen et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Clinical Value of 99mTc-3PRGD2 SPECT/CT in Differentiated Thyroid Carcinoma with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Level
Rui Gao et al.
SCIENTIFIC REPORTS (2018)
Tc-99m-3PRGD2 single-photon emission computed tomography/computed tomography for the diagnosis of choroidal melanoma A preliminary STROBE-compliant observational study
Bing Yan et al.
MEDICINE (2018)
Inter-heterogeneity and intra-heterogeneity of αvβ3 in non-small cell lung cancer and small cell lung cancer patients as revealed by 68Ga-RGD2 PET imaging
Fei Kang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
99mTc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma
Zhaoqi Zhang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2016)
Integrin Imaging with 99mTc-3PRGD2 SPECT/CT Shows High Specificity in the Diagnosis of Lymph Node Metastasis from Non-Small Cell Lung Cancer
Xiaona Jin et al.
RADIOLOGY (2016)
Comparison of the accuracy of 99mTc-3P4-RGD2 SPECT and CT in diagnosing solitary pulmonary nodules
Haishan Zhang et al.
ONCOLOGY LETTERS (2016)
99mTc-3PRGD2 SPECT/CT predicts the outcome of advanced nonsquamous non-small cell lung cancer receiving chemoradiotherapy plus bevacizumab
Qingjie Ma et al.
ANNALS OF NUCLEAR MEDICINE (2015)
99mTc-3PRGD2 SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer
Bin Ji et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer
Kun Zheng et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Early Events in Cell Spreading as a Model for Quantitative Analysis of Biomechanical Events
Haguy Wolfenson et al.
BIOPHYSICAL JOURNAL (2014)
Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from 68Ga-RGD PET/CT and 18F-FDG PET/CT
Hai-Jeon Yoon et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
99mTc-3P4-RGD2 Scintimammography in the Assessment of Breast Lesions: Comparative Study with 99mTc-MIBI
Qingjie Ma et al.
PLOS ONE (2014)
Comparison of 99mTc-3PRGD2 Integrin Receptor Imaging with 99mTc-MDP Bone Scan in Diagnosis of Bone Metastasis in Patients with Lung Cancer: A Multicenter Study
Weibing Miao et al.
PLOS ONE (2014)
18F-FPPRGD2 PET/CT: Pilot Phase Evaluation of Breast Cancer Patients
Andrei Lagaru et al.
RADIOLOGY (2014)
99mTc-3PRGD2 Scintimammography in Palpable and Nonpalpable Breast Lesions
Lin Liu et al.
MOLECULAR IMAGING (2014)
Elevated 99mTc 3PRGD2 Activity in Benign Metastasizing Leiomyoma
Xiaona Jin et al.
CLINICAL NUCLEAR MEDICINE (2013)
Combined 18F-FDG PET/CT and 99mTc 3PRGD2 SPECT/CT Imaging in a Case of Pituitary Metastases
Yuantao Hou et al.
CLINICAL NUCLEAR MEDICINE (2013)
PET-CT Evaluation of Solitary Pulmonary Nodules: Correlation with Maximum Standardized Uptake Value and Pathology
Yee Ting Sim et al.
LUNG (2013)
Biodistribution and Radiation Dosimetry of the Integrin Marker 18F-RGD-K5 Determined from Whole-Body PET/CT in Monkeys and Humans
Mohan Doss et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
99mTc-3PRGD2 for Integrin Receptor Imaging of Lung Cancer: A Multicenter Study
Zhaohui Zhu et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Integrin αvβ3 Imaging of Radioactive Iodine-Refractory Thyroid Cancer Using 99mTc-3PRGD2
Dan Zhao et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Differential diagnosis of solitary pulmonary nodules using 99mTc-3P4-RGD2 scintigraphy
Qingjie Ma et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Blood Clearance Kinetics, Biodistribution, and Radiation Dosimetry of a Kit-Formulated Integrin αvβ3-Selective Radiotracer 99mTc-3PRGD2 in Non-Human Primates
Bing Jia et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Pilot Pharmacokinetic and Dosimetric Studies of 18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3 Integrin Levels
Erik S. Mittra et al.
RADIOLOGY (2011)
Why Integrin as a Primary Target for Imaging and Therapy
Gang Niu et al.
THERANOSTICS (2011)
The role of positron emission tomography for non-small cell lung cancer
Albert J. Chang et al.
PRACTICAL RADIATION ONCOLOGY (2011)
Tumor Uptake of the RGD Dimeric Probe 99mTc-G3-2P4-RGD2 is Correlated with Integrin αvβ3 Expressed on both Tumor Cells and Neovasculature
Zhaofei Liu et al.
BIOCONJUGATE CHEMISTRY (2010)
Clinical applications of positron emission tomography-computed tomography in oncology
R. Kumar et al.
INDIAN JOURNAL OF CANCER (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography
Andrea Bille et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
Improving Tumor-Targeting Capability and Pharmacokinetics of Tc-99m-Labeled Cyclic RGD Dimers with PEG(4) Linkers
Lijun Wang et al.
MOLECULAR PHARMACEUTICS (2009)
The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent
Christophe Mariette et al.
ANNALS OF SURGERY (2008)
Improving Tumor Uptake and Excretion Kinetics of 99mTc-Labeled Cyclic Arginine-Glycine-Aspartic (RGD) Dimers with Triglycine Linkers
Jiyun Shi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
The Biodistribution and Radiation Dosimetry of the Arg-Gly-Asp Peptide 18F-AH111585 in Healthy Volunteers
Brian J. McParland et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Analysis of patients with false negative mammography and symptomatic breast carcinoma
Ian G. Murphy et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man
Ambros J. Beer et al.
CLINICAL CANCER RESEARCH (2006)
Integrins and angiogenesis: A sticky business
G Serini et al.
EXPERIMENTAL CELL RESEARCH (2006)
Endoscopic ultrasound for preoperative staging of esophageal carcinoma
X Zhang et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2005)
Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer
O Birim et al.
ANNALS OF THORACIC SURGERY (2005)
Integrins: roles in cancer development and as treatment targets
H Jin et al.
BRITISH JOURNAL OF CANCER (2004)
Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27,825 patient evaluations
TM Kolb et al.
RADIOLOGY (2002)
Role of integrins in cell invasion and migration
JD Hood et al.
NATURE REVIEWS CANCER (2002)
分享论文
